Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus.Adamas Pharmaceuticals announced its $450 million acquisition…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
